TXUE - ETF AI Analysis

Top Page

Thornburg International Equity ETF (TXUE)

Rating:65Neutral

Price Target:―

TXUE, the Thornburg International Equity ETF, has a solid but not outstanding overall rating, reflecting a mix of strong blue-chip holdings and some more mixed names. High-quality positions like AstraZeneca, TotalEnergies, Roche, and Mitsubishi UFJ support the fund’s rating through strong financial performance, positive earnings calls, and generally supportive technical trends. However, weaker or more mixed holdings such as E.ON, Orange, and ING, which face revenue, cash flow, or valuation challenges, along with the fund’s meaningful concentration in financials and European names, add risk and likely prevent a higher overall rating.

Positive Factors

Solid Recent Performance

The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.

Geographically Diversified International Exposure

Holdings spread across multiple countries in Europe, Japan, and North America help reduce the impact of weakness in any single market.

Broad Sector Mix

Exposure to a range of sectors such as industrials, financials, utilities, and health care provides diversification across different parts of the economy.

Negative Factors

Relatively High Expense Ratio

The fund’s expense ratio is on the higher side for an ETF, which can modestly reduce net returns over time.

Concentration in a Few Countries

A large portion of assets is concentrated in France and Japan, increasing sensitivity to economic or political issues in those markets.

Mixed Performance Among Top Holdings

While several top positions have performed strongly, a few key holdings have shown weak or negative performance, which can drag on overall returns.

TXUE vs. SPDR S&P 500 ETF (SPY)

AUM364.28M

RegionDeveloped Markets

Expense Ratio0.65%

Beta0.56

IssuerThornburg

Inception DateJan 21, 2025

Dividend Yield0.99%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume131,981

30 Day Avg. Volume45,996

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

36.41

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering45

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

TXUE Summary

Thornburg International Equity ETF (TXUE) is an international stock fund that invests in companies outside the U.S., without tracking a specific index. It spreads money across many countries like France, Japan, and Germany, and across sectors such as industrials, financials, and health care. Well-known holdings include AstraZeneca and Roche. An investor might choose TXUE to diversify beyond U.S. stocks and tap into growth from both developed and emerging markets. However, the value of this ETF can go up and down with global stock markets and currency moves.

How much will it cost me?The Thornburg International Equity ETF (TXUE) has an expense ratio of 0.65%, which means you’ll pay $6.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, meaning professionals are selecting and adjusting investments to optimize returns rather than following a preset index.

What would affect this ETF?The Thornburg International Equity ETF (TXUE) could benefit from growth in developed markets outside the U.S., particularly if industrial and financial sectors perform well, as they make up a significant portion of the fund's holdings. However, challenges such as rising interest rates or economic slowdowns in key regions could negatively impact these sectors and the ETF's overall performance. Additionally, regulatory changes or geopolitical tensions in countries where top holdings like AstraZeneca and TotalEnergies operate may pose risks.

TXUE Top 10 Holdings

TXUE leans heavily on big European and Japanese financials, with Mitsubishi UFJ, BNP Paribas, and ING acting as key engines for recent gains as their shares keep rising. Health care names like Roche have also been climbing, giving the fund a steady defensive backbone, while AstraZeneca’s more mixed, recently softer performance has taken a bit of shine off the sector. Utilities such as E.ON and Enel are plodding along rather than sprinting, which helps with stability but doesn’t turbocharge returns. Overall, this is a developed-markets, ex-U.S. story with a clear tilt toward banks and utilities over flashy tech.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ORA	ORANGE SA	4.20%	$15.26M	€45.61B	56.97%	65 Neutral
BNP	BNP Paribas	3.90%	$14.17M	€98.76B	30.18%	77 Outperform
8306	Mitsubishi UFJ Financial Group	3.51%	$12.76M	¥33.58T	57.63%	76 Outperform
NN	NN Group N.V.	3.39%	$12.33M	€17.12B	52.25%	68 Neutral
AZN	AstraZeneca	3.37%	$12.26M	£234.40B	29.12%	80 Outperform
EOAN	E.ON SE	3.37%	$12.26M	€48.52B	60.42%	61 Neutral
ROG	Roche Holding AG	3.24%	$11.79M	CHF287.83B	46.49%	73 Outperform
TTE	TotalEnergies SE	3.06%	$11.14M	€137.70B	9.16%	78 Outperform
IBE	Iberdrola	2.74%	$9.97M	€133.99B	47.44%	67 Neutral
INGA	ING GROEP	2.74%	$9.95M	€67.52B	46.49%	61 Neutral

TXUE Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

32.11

Positive

100DMA

31.14

Positive

200DMA

30.10

Positive

Market Momentum

MACD

0.62

Negative

RSI

68.10

Neutral

STOCH

85.75

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TXUE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 33.15, equal to the 50-day MA of 32.11, and equal to the 200-day MA of 30.10, indicating a bullish trend. The MACD of 0.62 indicates Negative momentum. The RSI at 68.10 is Neutral, neither overbought nor oversold. The STOCH value of 85.75 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TXUE.

TXUE Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
TXUE	―	―	$364.28M	0.65%	―
SEIE	―	―	$965.76M	0.50%	―
FYLD	―	―	$582.45M	0.59%	―
AVSD	―	―	$446.25M	0.23%	―
PPIE	―	―	$296.98M	0.49%	―
RFDI	―	―	$153.48M	0.83%	―

Performance Comparison

TXUE

Thornburg International Equity ETF

34.17

8.34

32.29%

SEIE

SEI Select International Equity ETF

―

FYLD

Cambria Foreign Shareholder Yield ETF

―

AVSD

Avantis Responsible International Equity ETF

―

PPIE

Putnam PanAgora ESG International Equity ETF

―

RFDI

First Trust Riverfront Dynamic Developed International ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents